Proactiveinvestors USA & Canada Hikma Pharmaceuticals plc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Hikma Pharmaceuticals plc. RSS feed en Sun, 15 Dec 2019 11:51:53 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Hikma and Vectura make new application for GSK knock-off https://www.proactiveinvestors.com/companies/news/907965/hikma-and-vectura-make-new-application-for-gsk-knock-off-907965.html Wed, 27 Nov 2019 08:59:00 -0500 https://www.proactiveinvestors.com/companies/news/907965/hikma-and-vectura-make-new-application-for-gsk-knock-off-907965.html Hikma says “successfully” launching new products, reiterates guidance https://www.proactiveinvestors.com/companies/news/906504/hikma-says-successfully-launching-new-products-reiterates-guidance-906504.html Thu, 07 Nov 2019 09:30:00 -0500 https://www.proactiveinvestors.com/companies/news/906504/hikma-says-successfully-launching-new-products-reiterates-guidance-906504.html Hikma looking healthy as it upgrades full-year forecasts following strong first half https://www.proactiveinvestors.com/companies/news/900436/hikma-looking-healthy-as-it-upgrades-full-year-forecasts-following-strong-first-half-900436.html Fri, 09 Aug 2019 07:15:00 -0400 https://www.proactiveinvestors.com/companies/news/900436/hikma-looking-healthy-as-it-upgrades-full-year-forecasts-following-strong-first-half-900436.html Hikma Pharma repeats guidance as it ‘gets off to good start’ in 2019 https://www.proactiveinvestors.com/companies/news/220487/hikma-pharma-repeats-guidance-as-it-gets-off-to-good-start-in-2019-220487.html Fri, 17 May 2019 07:45:00 -0400 https://www.proactiveinvestors.com/companies/news/220487/hikma-pharma-repeats-guidance-as-it-gets-off-to-good-start-in-2019-220487.html Hikma Pharma gets boost from Citigroup upgrade to ‘buy’ from ‘hold’ on growth outlook for 2019 https://www.proactiveinvestors.com/companies/news/216749/hikma-pharma-gets-boost-from-citigroup-upgrade-to-buy-from-hold-on-growth-outlook-for-2019-216749.html Tue, 19 Mar 2019 11:16:00 -0400 https://www.proactiveinvestors.com/companies/news/216749/hikma-pharma-gets-boost-from-citigroup-upgrade-to-buy-from-hold-on-growth-outlook-for-2019-216749.html Hikma Pharma falls as it narrowly misses forecasts with 2018 results https://www.proactiveinvestors.com/companies/news/216368/hikma-pharma-falls-as-it-narrowly-misses-forecasts-with-2018-results-216368.html Wed, 13 Mar 2019 09:27:00 -0400 https://www.proactiveinvestors.com/companies/news/216368/hikma-pharma-falls-as-it-narrowly-misses-forecasts-with-2018-results-216368.html Hikma Pharmaceuticals secures anti-viral licensing deal https://www.proactiveinvestors.com/companies/news/211902/hikma-pharmaceuticals-secures-anti-viral-licensing-deal-211902.html Thu, 03 Jan 2019 09:21:00 -0500 https://www.proactiveinvestors.com/companies/news/211902/hikma-pharmaceuticals-secures-anti-viral-licensing-deal-211902.html Hikma Pharma gets shot in the arm from licensing and supply deal with China's Hansoh; Jefferies upgrade https://www.proactiveinvestors.com/companies/news/210035/hikma-pharma-gets-shot-in-the-arm-from-licensing-and-supply-deal-with-china-s-hansoh-jefferies-upgrade-210035.html Tue, 27 Nov 2018 12:23:00 -0500 https://www.proactiveinvestors.com/companies/news/210035/hikma-pharma-gets-shot-in-the-arm-from-licensing-and-supply-deal-with-china-s-hansoh-jefferies-upgrade-210035.html Hikma Pharma moved to ‘Hold’ from ‘Add’ by Peel Hunt on valuation grounds, says forecast upgrades already priced in https://www.proactiveinvestors.com/companies/news/209007/hikma-pharma-moved-to-hold-from-add-by-peel-hunt-on-valuation-grounds-says-forecast-upgrades-already-priced-in-209007.html Mon, 12 Nov 2018 10:13:00 -0500 https://www.proactiveinvestors.com/companies/news/209007/hikma-pharma-moved-to-hold-from-add-by-peel-hunt-on-valuation-grounds-says-forecast-upgrades-already-priced-in-209007.html Hikma and Vectura to develop generic version of GSK’s blockbuster Ellipta inhaler https://www.proactiveinvestors.com/companies/news/208820/hikma-and-vectura-to-develop-generic-version-of-gsks-blockbuster-ellipta-inhaler-208820.html Thu, 08 Nov 2018 09:25:00 -0500 https://www.proactiveinvestors.com/companies/news/208820/hikma-and-vectura-to-develop-generic-version-of-gsks-blockbuster-ellipta-inhaler-208820.html Hikma Pharma zips higher as it upgrades full-year guidance following strong first half https://www.proactiveinvestors.com/companies/news/202938/hikma-pharma-zips-higher-as-it-upgrades-full-year-guidance-following-strong-first-half-202938.html Wed, 15 Aug 2018 08:47:00 -0400 https://www.proactiveinvestors.com/companies/news/202938/hikma-pharma-zips-higher-as-it-upgrades-full-year-guidance-following-strong-first-half-202938.html Numis cuts Hikma Pharma to ‘hold’ from ‘add’ on valuation grounds ahead of upcoming interims https://www.proactiveinvestors.com/companies/news/202578/numis-cuts-hikma-pharma-to-hold-from-add-on-valuation-grounds-ahead-of-upcoming-interims-202578.html Thu, 09 Aug 2018 10:51:00 -0400 https://www.proactiveinvestors.com/companies/news/202578/numis-cuts-hikma-pharma-to-hold-from-add-on-valuation-grounds-ahead-of-upcoming-interims-202578.html Numis Securities trims rating for Hikma Pharmaceuticals to ‘add’ from ‘buy’ on valuation grounds after update https://www.proactiveinvestors.com/companies/news/197278/numis-securities-trims-rating-for-hikma-pharmaceuticals-to-add-from-buy-on-valuation-grounds-after-update-197278.html Fri, 18 May 2018 10:17:00 -0400 https://www.proactiveinvestors.com/companies/news/197278/numis-securities-trims-rating-for-hikma-pharmaceuticals-to-add-from-buy-on-valuation-grounds-after-update-197278.html Hikma Pharmaceuticals shares slip as guidance maintained though current year has got off to “an encouraging start” https://www.proactiveinvestors.com/companies/news/197260/hikma-pharmaceuticals-shares-slip-as-guidance-maintained-though-current-year-has-got-off-to-an-encouraging-start-197260.html Fri, 18 May 2018 08:05:00 -0400 https://www.proactiveinvestors.com/companies/news/197260/hikma-pharmaceuticals-shares-slip-as-guidance-maintained-though-current-year-has-got-off-to-an-encouraging-start-197260.html Drugs working for Hikma Pharma as shares propelled higher by rating upgrades from both Citigroup and Jefferies https://www.proactiveinvestors.com/companies/news/193232/drugs-working-for-hikma-pharma-as-shares-propelled-higher-by-rating-upgrades-from-both-citigroup-and-jefferies-193232.html Thu, 15 Mar 2018 11:53:00 -0400 https://www.proactiveinvestors.com/companies/news/193232/drugs-working-for-hikma-pharma-as-shares-propelled-higher-by-rating-upgrades-from-both-citigroup-and-jefferies-193232.html Hikma Pharmaceuticals posts loss after US write-down https://www.proactiveinvestors.com/companies/news/193141/hikma-pharmaceuticals-posts-loss-after-us-write-down-193141.html Wed, 14 Mar 2018 14:27:00 -0400 https://www.proactiveinvestors.com/companies/news/193141/hikma-pharmaceuticals-posts-loss-after-us-write-down-193141.html Hikma Pharmaceuticals and Vectura hit by US regulatory setback https://www.proactiveinvestors.com/companies/news/192974/hikma-pharmaceuticals-and-vectura-hit-by-us-regulatory-setback-192974.html Mon, 12 Mar 2018 08:02:00 -0400 https://www.proactiveinvestors.com/companies/news/192974/hikma-pharmaceuticals-and-vectura-hit-by-us-regulatory-setback-192974.html Barclays double-downgrades Hikma to ‘underweight’ but sees appointment of new CEO as positive https://www.proactiveinvestors.com/companies/news/192429/barclays-double-downgrades-hikma-to-underweight-but-sees-appointment-of-new-ceo-as-positive-192429.html Thu, 01 Mar 2018 11:29:00 -0500 https://www.proactiveinvestors.com/companies/news/192429/barclays-double-downgrades-hikma-to-underweight-but-sees-appointment-of-new-ceo-as-positive-192429.html Hikma shares rise as it appoints former Teva executive as CEO https://www.proactiveinvestors.com/companies/news/191897/hikma-shares-rise-as-it-appoints-former-teva-executive-as-ceo-191897.html Tue, 20 Feb 2018 09:58:00 -0500 https://www.proactiveinvestors.com/companies/news/191897/hikma-shares-rise-as-it-appoints-former-teva-executive-as-ceo-191897.html Hikma Pharmaceuticals top mid-cap casualty as Jefferies International downgrades https://www.proactiveinvestors.com/companies/news/189804/hikma-pharmaceuticals-top-mid-cap-casualty-as-jefferies-international-downgrades-189804.html Wed, 10 Jan 2018 12:05:00 -0500 https://www.proactiveinvestors.com/companies/news/189804/hikma-pharmaceuticals-top-mid-cap-casualty-as-jefferies-international-downgrades-189804.html Jefferies International calls the floor on Hikma Pharma shares following profit warning slide https://www.proactiveinvestors.com/companies/news/182736/jefferies-international-calls-the-floor-on-hikma-pharma-shares-following-profit-warning-slide-182736.html Mon, 21 Aug 2017 14:52:00 -0400 https://www.proactiveinvestors.com/companies/news/182736/jefferies-international-calls-the-floor-on-hikma-pharma-shares-following-profit-warning-slide-182736.html Hikma sounds the earnings alarm sending shares crashing https://www.proactiveinvestors.com/companies/news/182589/hikma-sounds-the-earnings-alarm-sending-shares-crashing-182589.html Thu, 17 Aug 2017 07:36:00 -0400 https://www.proactiveinvestors.com/companies/news/182589/hikma-sounds-the-earnings-alarm-sending-shares-crashing-182589.html Hikma's shares plunge after cutting full year revenue forecast on asthma drug launch delay https://www.proactiveinvestors.com/companies/news/178045/hikma-s-shares-plunge-after-cutting-full-year-revenue-forecast-on-asthma-drug-launch-delay-178045.html Fri, 19 May 2017 14:35:00 -0400 https://www.proactiveinvestors.com/companies/news/178045/hikma-s-shares-plunge-after-cutting-full-year-revenue-forecast-on-asthma-drug-launch-delay-178045.html Hikma Pharmaceuticals hit by downgrade prompted by Advair delay fears https://www.proactiveinvestors.com/companies/news/177918/hikma-pharmaceuticals-hit-by-downgrade-prompted-by-advair-delay-fears-177918.html Wed, 17 May 2017 08:42:00 -0400 https://www.proactiveinvestors.com/companies/news/177918/hikma-pharmaceuticals-hit-by-downgrade-prompted-by-advair-delay-fears-177918.html Hikma Pharmaceuticals reports decline in full year profit but shares rise as it beats forecasts https://www.proactiveinvestors.com/companies/news/174810/hikma-pharmaceuticals-reports-decline-in-full-year-profit-but-shares-rise-as-it-beats-forecasts-174810.html Wed, 15 Mar 2017 09:30:00 -0400 https://www.proactiveinvestors.com/companies/news/174810/hikma-pharmaceuticals-reports-decline-in-full-year-profit-but-shares-rise-as-it-beats-forecasts-174810.html Drugs stocks boosted by Clinton defeat https://www.proactiveinvestors.com/companies/news/168740/drugs-stocks-boosted-by-clinton-defeat-168740.html Wed, 09 Nov 2016 08:46:00 -0500 https://www.proactiveinvestors.com/companies/news/168740/drugs-stocks-boosted-by-clinton-defeat-168740.html Hikma Pharmaceuticals hits Footsie as oil and mining dip https://www.proactiveinvestors.com/companies/news/126671/hikma-pharmaceuticals-hits-footsie-as-oil-and-mining-dip-126671.html Thu, 02 Jun 2016 11:10:00 -0400 https://www.proactiveinvestors.com/companies/news/126671/hikma-pharmaceuticals-hits-footsie-as-oil-and-mining-dip-126671.html Hikma Pharmaceuticals wins US approval for surgical recovery drug https://www.proactiveinvestors.com/companies/news/120930/hikma-pharmaceuticals-wins-us-approval-for-surgical-recovery-drug-120930.html Mon, 04 Jan 2016 12:15:00 -0500 https://www.proactiveinvestors.com/companies/news/120930/hikma-pharmaceuticals-wins-us-approval-for-surgical-recovery-drug-120930.html Hikma Pharmaceutical hobbled by gout treatment https://www.proactiveinvestors.com/companies/news/116935/hikma-pharmaceutical-hobbled-by-gout-treatment-116935.html Mon, 02 Nov 2015 12:11:00 -0500 https://www.proactiveinvestors.com/companies/news/116935/hikma-pharmaceutical-hobbled-by-gout-treatment-116935.html Hikma boosts presence in Egypt with EUP purchase https://www.proactiveinvestors.com/companies/news/110604/hikma-boosts-presence-in-egypt-with-eup-purchase-110604.html Tue, 08 Sep 2015 06:54:00 -0400 https://www.proactiveinvestors.com/companies/news/110604/hikma-boosts-presence-in-egypt-with-eup-purchase-110604.html Investors should run from Sports Direct, Peel Hunt reckons https://www.proactiveinvestors.com/companies/news/272889/investors-should-run-from-sports-direct-peel-hunt-reckons-22889.html Fri, 04 Sep 2015 07:38:00 -0400 https://www.proactiveinvestors.com/companies/news/272889/investors-should-run-from-sports-direct-peel-hunt-reckons-22889.html Hikma Pharmaceuticals H1 profit falls on a decline in generics https://www.proactiveinvestors.com/companies/news/110079/hikma-pharmaceuticals-h1-profit-falls-on-a-decline-in-generics-110079.html Wed, 19 Aug 2015 07:10:00 -0400 https://www.proactiveinvestors.com/companies/news/110079/hikma-pharmaceuticals-h1-profit-falls-on-a-decline-in-generics-110079.html Hikma buys Roxane Labs from Boehringer https://www.proactiveinvestors.com/companies/news/109417/hikma-buys-roxane-labs-from-boehringer-109417.html Tue, 28 Jul 2015 08:23:00 -0400 https://www.proactiveinvestors.com/companies/news/109417/hikma-buys-roxane-labs-from-boehringer-109417.html Hikma Pharmaceuticals receives warning over Portugal facility https://www.proactiveinvestors.com/companies/news/63007/hikma-pharmaceuticals-receives-warning-over-portugal-facility-73616.html Fri, 24 Oct 2014 07:11:00 -0400 https://www.proactiveinvestors.com/companies/news/63007/hikma-pharmaceuticals-receives-warning-over-portugal-facility-73616.html Hikma Pharmaceuticals upgraded by Goldman Sachs https://www.proactiveinvestors.com/companies/news/60110/hikma-pharmaceuticals-upgraded-by-goldman-sachs-70504.html Fri, 18 Jul 2014 07:23:00 -0400 https://www.proactiveinvestors.com/companies/news/60110/hikma-pharmaceuticals-upgraded-by-goldman-sachs-70504.html Baxter sells generic injectables unit to Hikma Pharmaceuticals for US$112m https://www.proactiveinvestors.com/companies/news/18890/baxter-sells-generic-injectables-unit-to-hikma-pharmaceuticals-for-us112m-22586.html Mon, 01 Nov 2010 06:40:00 -0400 https://www.proactiveinvestors.com/companies/news/18890/baxter-sells-generic-injectables-unit-to-hikma-pharmaceuticals-for-us112m-22586.html